Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Chantal Pharand"'
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 13, Iss 1, Pp 21-27 (2002)
OBJECTIVE: To characterize national and regional patterns of antimicrobial prophylaxis in adult cardiac surgery across Canada.
Externí odkaz:
https://doaj.org/article/5a34d44ca79c4efcbc201a9cd93375aa
Autor:
Margaret L. Ackman, Patrick Robertson, Michael Callaghan, Heather Kertland, Claudia Bucci, William Semchuk, Chantal Pharand
Publikováno v:
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 148:71-81
The initial Canadian Cardiovascular Society (CCS) Guidelines on the Use of Antiplatelet Therapy1 covered chronic antiplatelet therapy for a number of diseases and patient subgroups. The 2012 Focused Update2 specifically addressed the issues of antipl
Autor:
Erick Schampaert, Chantal Pharand, Marie Lordkipanidzé, Jean G. Diodati, Jacques Turgeon, Donald A. Palisaitis
Publikováno v:
International Journal of Cardiology. 143:43-50
Background: Several patient characteristics have been shown to increase the risk of inadequate platelet inhibition by aspirin, yet underlying mechanisms remain mostly unknown. We explored whether oxidative stress, via isoprostane formation, was assoc
Autor:
Thao Huynh, James Nasmith, The Minh Luong, Martin Bernier, Chantal Pharand, Zhao Xue-Qiao, Robert P. Giugliano, Pierre Theroux
Publikováno v:
Canadian Journal of Cardiology. 25:e417-e421
Although the Thrombolysis In Myocardial Infarction (TIMI) score incorporates ST deviation, it does not account for characteristics of the ST deviations. In the present study, it was hypothesized that the magnitude and characteristics of ST deviation
Autor:
Jean G. Diodati, Erick Schampaert, Marie Lordkipanidzé, Donald A. Palisaitis, Chantal Pharand
Publikováno v:
Thrombosis Research. 124:418-422
Hyporesponsiveness to antiplatelet agents has been linked to an increased risk of major adverse cardiovascular events. However, light transmission aggregometry (LTA), the gold standard methodology for assessing platelet function, requires expertise a
Autor:
Jacques Turgeon, Chantal Pharand, Marie Lordkipanidzé, Donald A. Palisaitis, Thuy Anh Nguyen, Jean G. Diodati, Erick Schampaert
Publikováno v:
Journal of Interventional Cardiology. 22:368-377
Background: Adequate platelet inhibition before percutaneous coronary intervention (PCI) reduces periprocedural and long-term ischemic complications. Reduced response to clopidogrel has been associated with subsequent major adverse cardiovascular eve
Autor:
Jean G. Diodati, Normand Blais, Ying K. Sia, Chantal Pharand, Marie Lordkipanidzé, Yahye Merhi
Publikováno v:
Thrombosis and Haemostasis. 102:404-411
Variable biological effect of aspirin is suggested to be related to pharmacological resistance. The incidence of this so-called "resistant" state varies with the study population and the assay used. We determined performance features of five assays u
Publikováno v:
Therapeutic Drug Monitoring. 30:372-378
The emergence of point-of-care assays enabling bedside testing such as the VerifyNow P2Y12 system might prove useful in clinical settings. The aim of this study was to evaluate the ability of the VerifyNow P2Y12 assay to estimate the inhibition of pl
Autor:
Marie Lordkipanidzé, Erick Schampaert, Donald A. Palisaitis, Jacques Turgeon, Chantal Pharand, Jean G. Diodati
Publikováno v:
European Heart Journal. 28:1702-1708
Aims We sought to compare the results obtained from six major platelet function tests in the assessment of the prevalence of aspirin resistance in patients with stable coronary artery disease. Methods and results 201 patients with stable coronary art
Publikováno v:
Pharmacology & Therapeutics. 112:733-743
Acetylsalicylic acid, or aspirin (ASA), is widely used in patients with cardiovascular disease to prevent acute ischemic events. However, platelet response to ASA is not equal in all individuals, and a high variability in the prevalence of ASA resist